Key Stats for Cognex Stock
- Past-Week Performance: -3%
- 52-Week Range: $22.7 to $59.9
- Current Price: $53.17
What Happened?
Cognex Corporation (CGNX) crossed $1 billion in served-market penetration potential just as its first-ever AI cloud training platform prepares for full commercial launch, with the stock at $53.17 sitting 122% above its 52-week low.
Five Wall Street firms raised price targets on Feb. 13 following Q4 results, with UBS lifting to $70 and Bernstein pushing to $66, framing Cognex as a margin expansion story rather than a cyclical recovery play.
The company delivered 22.7% adjusted EBITDA margin in Q4, the sixth consecutive quarter of year-over-year expansion, while free cash flow surged 77% to $237 million in full-year 2025, the highest since 2021.
Beyond the analyst upgrades, Cognex added 9,000 new customer accounts in 2025, 3x the 2024 rate, while simultaneously announcing a $35 million to $40 million annualized OpEx reduction targeting a 25% adjusted EBITDA run rate by year-end 2026.
CEO Matt Moschner stated on the Q4 earnings call that “2025 marks a return to profitable growth for Cognex, with constant currency revenue growth of 8% year-over-year and adjusted EPS growth of 38%,” directly validating the raised through-cycle EBITDA range of 25% to 31%.
With OneVision launching to all customers this spring, packaging growth accelerating, and semiconductor demand set to pick up in the back half of 2026, Cognex is turning its $7 billion market into a multi-year growth story, not just a one-cycle bounce.
Wall Street’s Take on CGNX Stock
The Q4 earnings beat and $35 million to $40 million OpEx reduction force analysts to re-evaluate Cognex from cyclical recovery to a durable margin expansion platform with structural pricing power returning.
Street estimates project 2026 revenue of $1.07 billion, up 7.7%, with EBITDA margins growing to 24.0% from 21.5% in 2025, showing the profit improvement is already showing up in the numbers.
As of March 5, 20 analysts cover CGNX with 11 buys, 4 outperforms, 5 holds, and 1 underperform, producing a mean price target of $65.35 representing 22.9% upside from the current $53.17 price.
The high target of $80.00 prices in full execution on the 25%-to-31% through-cycle EBITDA framework, while the $52.00 low target reflects the risk that the $22 million portfolio exit disrupts near-term revenue momentum.
What Does the Valuation Model Say?
This TIKR mid-case puts fair value at $82.81 by Dec. 31, 2030, implying 55.7% total return from current levels at a 9.6% annualized IRR.
The market is pricing Cognex as a mid-cycle industrial name, ignoring the OneVision platform’s ability to structurally expand addressable applications within the $7 billion served market.
The 10-year revenue CAGR of 8.2% historically came without the current AI-enabled product suite, yet the stock trades well below the valuation levels that history produced with weaker fundamentals.
Management’s $500 million buyback authorization increase alongside a 9,000 new customer acquisition rate signals the leadership team believes the stock materially undervalues the compounding capacity now embedded in the business.
The primary risk is automotive and European weakness persisting beyond 2026, which could drag the company’s flat-to-low-single-digit automotive growth assumption and compress the margin expansion timeline.
The Q1 2026 earnings call is the next moment of truth, where investors will confirm whether the 13% revenue growth guide and early semiconductor acceleration are holding into spring.
CGNX is a buy-building thesis with 22.9% near-term upside to consensus; monitor adjusted EBITDA margin progression quarterly as the single metric separating re-rating from stagnation.
Should You Invest in Cognex Corporation?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up CGNX stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Cognex Corporation alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze CGNX stock on TIKR for Free →
